Complete Abortion Clinical Trial
Official title:
Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Kazakhstan: A Study of 600 µg Sublingual Misoprostol Following 200 mg Mifepristone for Abortion up to 70 Days Gestation
The study will be conducted in 4 sites and will examine how a simplified outpatient medical
abortion procedure using mifepristone and misoprostol, with the option to take mifepristone
at a place of woman's choosing, works in Kazakhstan. The investigators intend to demonstrate
the efficacy of oral administration of 200 mg mifepristone and sublingual administration of
600 µg misoprostol with gestations through 70 days, as well as the acceptability of this
method. Research questions include:
1. What is the efficacy of regimen of 200 mg mifepristone, followed 24 to 48 hours later
by 600 µg sublingual misoprostol and used in gestations of up to 70 days?
2. Is medical abortion procedure consisting of two visits acceptable to women in
Kazakhstan?
3. Are the side effects associated with sublingual use of misoprostol acceptable to women?
4. When given a choice, do women prefer to take mifepristone in the clinic or at a place
of their choosing?
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01475318 -
Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of Pregnancy
|
N/A | |
| Completed |
NCT01387256 -
Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone
|
Phase 4 |